Shots:
- The companies will co-develop a first-of-its-kind, single-use flow-through polishing system for GMP operation. The collaboration expected to accelerate affordable access to therapeutics for patients in China and globally
- The agreement will initially focus on developing and designing the process technologies and automation while later focus on the expanded scope of the process and digital technologies to optimize a continuous manufacturing process
- The collaboration leverages Merck’s BioContinuum platform and expertise in continuous processing to aid Transcenta’s vision in implementing fully continuous bioprocessing in GMP manufacturing in China
Click here to read full press release/ article | Ref: PRNewswire | Image: Addvalue
The post Merck and Transcenta Collaborate to Implement Continuous Manufacturing for Protein Therapeutics first appeared on PharmaShots.
